Market Indices
Latest News
 |
| ||
| ||
| ||
|
Price Targets
from Roth Capital issued a price target of $10.00 for LCUT on 2026-07-13 12:39:28.The adjusted price target was set to $10.00.At the time of the announcement, LCUT...
July 13, 2026 LCUT 4.83%
from Piper Sandler issued a price target of $5.00 for EARN on 2026-07-13 10:59:21.The adjusted price target was set to $5.00.At the time of the announcement, EARN...
July 13, 2026 EARN -1.02%
from Needham issued a price target of $43.00 for PKE on 2026-07-13 10:45:01.The adjusted price target was set to $43.00.At the time of the announcement, PKE was...
July 13, 2026 PKE -0.39%
from Stifel Nicolaus issued a price target of $10.00 for EOSE on 2026-07-13 10:44:53.The adjusted price target was set to $10.00.At the time of the announcement, EOSE...
July 13, 2026 EOSE -2.61%
from H.C. Wainwright issued a price target of $5.00 for OKYO on 2026-07-13 10:38:00.The adjusted price target was set to $5.00.At the time of the announcement, OKYO...
July 13, 2026 OKYO -6.21%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| AGEN Agenus Inc. | 6.22
85.52% | ||||||||||||||||||
| LTCH Latch, Inc. | 0.19
18.47% | ||||||||||||||||||
| GALT Galectin Therapeutics Inc | 4.60
13.30% | ||||||||||||||||||
| ARAY Accuray Incorporated | 0.27
11.98% | ||||||||||||||||||
| JSPRW Jasper Therapeutics, Inc. | 0.01
9.92% | ||||||||||||||||||
| TLSA Tiziana Life Sciences Ltd | 1.34
8.94% | ||||||||||||||||||
| CSTE Caesarstone Ltd. | 2.56
8.02% | ||||||||||||||||||
| NRT North European Oil Royalt | 7.89
7.87% | ||||||||||||||||||
Annual/Quarterly Reports Summary
In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...
November 6, 2024 AIP -6.31%
In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...
November 6, 2024 EOSEW -34.96%
In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...
November 6, 2024 EOSE -2.61%
In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...
November 5, 2024 STOK -4.60%
In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...
November 5, 2024 BSVN -0.40%